Abstract

IntroductionPersistent low rates of case notification and treatment coverage reflect that accessing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in Nigeria remains a challenge, even though it is provided free of charge to patients. Equity in health access requires availability of comparable, appropriate services to all, based on needs, and irrespective of socio-demographic characteristics. Our study aimed to identify the reasons for Nigeria’s low rates of case-finding and treatment for DR-TB. To achieve this, we analyzed elements that facilitate or hinder equitable access for different groups of patients within the current health system to support DR-TB management in Nigeria.MethodsWe conducted documentary review of guidelines and workers manuals, as well as 57 qualitative interviews, including 10 focus group discussions, with a total of 127 participants, in Nigeria. Between August and November 2017, we interviewed patients who were on treatment, their treatment supporter, and providers in Ogun and Plateau States, as well as program managers in Benue and Abuja. We adapted and used Levesque’s patient-centered access to care framework to analyze DR-TB policy documents and interview data.ResultsThematic analysis revealed inequitable access to DR-TB care for some patient socio-demographic groups. While patients were mostly treated equally at the facility level, some patients experienced more difficulty accessing care based on their gender, age, occupation, educational level and religion. Health system factors including positive provider attitudes and financial support provided to the patients facilitated equity and ease of access. However, limited coverage and the absence of patients’ access rights protection and considerations in the treatment guidelines and workers manuals likely hampered access.ConclusionIn the context of Nigeria’s low case-finding and treatment coverage, applying an equity of access framework was necessary to highlight gaps in care. Differing social contexts of patients adversely affected their access to DR-TB care. We identified several strengths in DR-TB care delivery, including the current financial support that should be sustained. Our findings highlight the need for government’s commitment and continued interventions.

Highlights

  • Persistent low rates of case notification and treatment coverage reflect that accessing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in Nigeria remains a challenge, even though it is provided free of charge to patients

  • Health system factors including positive provider attitudes and financial support provided to the patients facilitated equity and ease of access

  • Study population and data collection We reviewed several National TB and Leprosy Control Program (NTBLCP) and Federal Ministry of Health (FMOH) policy and guideline [43,44,45] documents including the workers’ manual [46] and the 2015 annual TB program report [9], some unpublished program data [47,48,49] and World Health Organisation (WHO) country profile [1]

Read more

Summary

Introduction

Persistent low rates of case notification and treatment coverage reflect that accessing diagnosis and treatment for drug-resistant tuberculosis (DR-TB) in Nigeria remains a challenge, even though it is provided free of charge to patients. About 11 and 9% of estimated DR-TB cases were notified and initiated on treatment, respectively [1] This highlights major difficulties in accessing DR-TB care [1]. With a per capita GDP of USD 5864, 8 and 32% of the TB budget was domestic and donor funded respectively. This leaves 60% of the National TB budget required to implement the Stop TB Partnership’s Global Plan to End TB 2018– 2022 unfunded [1, 3, 4]. 71 % of TB patients faced catastrophic health costs in 2017 [1]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call